DRC Launches Record Ebola Trial

By Catamist AI AI summary

Summarized by Catamist’s AI from other outlets’ reporting and checked for neutrality. Original sources are linked below.

In a groundbreaking move against the Bundibugyo Ebola strain, researchers in the Democratic Republic of Congo have initiated record-fast clinical trials for two promising antiviral drugs, notably including pregnant and breastfeeding women often excluded from medical research. This urgent response addresses the third-largest Ebola outbreak on record, declared a Public Health Emergency, with Oxford University simultaneously launching the world's first human trials for a Bundibugyo vaccine amidst significant safety concerns and operational challenges in affected regions.

Researchers in the Democratic Republic of Congo (DRC) have initiated a record-fast clinical trial for two promising antiviral drugs to combat the ongoing Ebola outbreak, caused by the Bundibugyo strain for which no approved treatment or vaccine currently exists, as reported by goodgoodgood.co.
The trial is notable for its unprecedented speed and scale, specifically including pregnant and breastfeeding women who are often excluded from medical research, according to goodgoodgood.co and The Guardian.
The primary trial, known as EBO-PEP, is testing Gilead Sciences' experimental antiviral obeldesivir as a post-exposure treatment for high-risk contacts, with a separate compassionate-use protocol for remdesivir for children under 12 and pregnant/breastfeeding women, as detailed by Reuters and ReliefWeb.
However, response efforts in the worst-affected regions are being limited by safety concerns, attacks on health facilities, and unpaid salaries for health workers, goodgoodgood.co noted.
In a parallel development, Oxford University has launched the world's first Phase I clinical trial for a vaccine targeting the Bundibugyo ebolavirus, with human trials underway in the UK, as reported by CNBC Africa and SABC News.
The current Bundibugyo Ebola outbreak in the DRC has been declared a Public Health Emergency of International Concern by the World Health Organization and is already the third largest Ebola outbreak on record, according to The BMJ and ReliefWeb.